Tempus

Chicago, United States

Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.

May 2026

Post-IPO Debt

Top Investors

Franklin TempletonNovo HoldingsAres ManagementNew Enterprise AssociatesBaillie Gifford

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Tempus's investors?

Tempus's investors include Franklin Templeton, Novo Holdings, Ares Management, New Enterprise Associates, Baillie Gifford.

Where is Tempus headquartered?

Tempus is headquartered in Chicago, United States.

What does Tempus do?

Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.

What stage is Tempus at?

Tempus is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 8, 2026.

MLA

"Tempus — Funding & Investors." VCBacked, May 8, 2026, https://www.vcbacked.co/company/tempus. Accessed June 3, 2026.

APA

VCBacked. (2026). Tempus — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/tempus

Wikipedia (cite web)

{{cite web |title=Tempus — Funding & Investors |url=https://www.vcbacked.co/company/tempus |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 8, 2026.